# Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

> **NCT04082000** · PHASE1,PHASE2 · TERMINATED · sponsor: **Breath of Life International Pharma Ltd** · enrollment: 2 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** BOL-DP-o-04
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04082000
- **Lead sponsor:** Breath of Life International Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-15
- **Primary completion:** 2020-11-04
- **Final completion:** 2020-11-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** study stopped due to company strategic prioritization
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082000, "Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04082000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*